Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study

1. Carmona-Bayonas, A. ¹
2. Jiménez-Fonseca, P. ²
3. Lamarca, Á. ³
4. Barriuso, J. ³⁴
5. Castaño, Á. ⁵
6. Benavent, M. ⁶
7. Alonso, V. ⁷
8. Riesco-Martínez, M.D.C. ⁸
9. Alonso-Gordoa, T. ⁹
10. Custodio, A. ¹⁰
11. Sánchez Cánovas, M. ¹
12. Hernando Cubero, J. ¹¹
13. López, C. ¹²
14. Lacasta, A. ¹³
15. Fernández Montes, A. ¹⁴
16. Marazuela, M. ¹⁵
17. Crespo, G. ¹⁶
18. Escudero, P. ¹⁷
19. Diaz, J.Á. ¹⁸
20. Feliciangeli, E. ¹⁹
21. Gallego, J. ²⁰
22. Llanos, M. ²¹
23. Segura, Á. ²²
24. Vilardell, F. ²³
25. Percovich, J.C. ²⁴
26. Grande, E. ²⁵
27. Capdevila, J. ¹¹
28. Valle, J.W. ³⁴
29. García-Carbonero, R. ⁸
30. Show all authors +